SeekingAlpha · Sep 29, 2026
Nu Skin: The Turnaround Is Behind Before It's Started
Nu Skin hits a 25-year low as revenue slides. See valuation metrics (P/E, EV/EBITDA, 5%+ yield) and decide if itâs a value trapâread more on NUS stock.
NU
NYSE · NUS
Nu Skin Enterprises, Inc.
Consumer Defensive · Household & Personal Products
$4.98
Up+$0.01 (+0.20%)
Updated Oct 21, 2026, 3:28 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 518.35M
- P/E ratio
- 4.71
- Dividend yield
- 4.82%
- 52-week range
- $4.45 – $8.08
- Volume
- 327.61K
- Avg. volume
- 507.91K
Price performance · NUS
NUS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 20, 2026
NUS closed at $4.98 after 21 trading sessions, up 2.47% for the selected period.
- Last close
- $4.98
- Period change
- +2.47%
- Period low
- $4.53
- Period high
- $5.21
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | $5.02 | $5.08 | $4.97 | $4.98 | 327.61K |
| Oct 19, 2026 | $5.12 | $5.15 | $4.96 | $4.97 | 323.57K |
| Oct 16, 2026 | $5.24 | $5.39 | $5.11 | $5.14 | 572.31K |
| Oct 15, 2026 | $5.16 | $5.335 | $5.16 | $5.21 | 511.36K |
| Oct 14, 2026 | $5.03 | $5.12 | $4.985 | $5.11 | 421.39K |
| Oct 13, 2026 | $4.90 | $5.02 | $4.88 | $5.01 | 492.9K |
| Oct 12, 2026 | $4.74 | $4.92 | $4.695 | $4.87 | 590.9K |
| Oct 9, 2026 | $4.77 | $4.855 | $4.73 | $4.74 | 327.3K |
| Oct 8, 2026 | $4.80 | $4.81 | $4.705 | $4.77 | 571.4K |
| Oct 7, 2026 | $4.71 | $4.855 | $4.69 | $4.80 | 482.67K |
| Oct 6, 2026 | $4.67 | $4.795 | $4.64 | $4.74 | 405.45K |
| Oct 5, 2026 | $4.62 | $4.66 | $4.54 | $4.63 | 458.92K |
| Oct 2, 2026 | $4.59 | $4.66 | $4.52 | $4.61 | 376.37K |
| Oct 1, 2026 | $4.51 | $4.55 | $4.445 | $4.55 | 693.33K |
| Sep 30, 2026 | $4.63 | $4.65 | $4.49 | $4.53 | 720.92K |
| Sep 29, 2026 | $4.65 | $4.73 | $4.59 | $4.59 | 415.43K |
| Sep 28, 2026 | $4.62 | $4.7036 | $4.575 | $4.64 | 317.14K |
| Sep 25, 2026 | $4.62 | $4.67 | $4.59 | $4.63 | 369.97K |
| Sep 24, 2026 | $4.63 | $4.70 | $4.56 | $4.62 | 428.93K |
| Sep 23, 2026 | $4.83 | $4.84 | $4.61 | $4.61 | 327.31K |
| Sep 22, 2026 | $4.74 | $4.88 | $4.74 | $4.86 | 507.99K |
Latest NUS news
The latest Smart Investors Daily articles mentioning NUS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
NUS research
Overview
Company profile and research snapshot.
Company profile
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $11.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Dec 20, 2024 | DA Davidson | Neutral | — |
| Oct 22, 2024 | Citigroup | Neutral | — |
| Aug 12, 2024 | DA Davidson | Neutral | — |
| Aug 9, 2024 | Citigroup | Neutral | — |
| May 9, 2024 | DA Davidson | Neutral | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 3, 2026
Nu Skin Ranked the World’s #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
PROVO, Utah, September 03, 2026--Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world’s No. 1 company for beauty and wellness device systems by Euromonitor International Ltd. for the third consecutive year.*
Fintel · Aug 28, 2026
Nu Skin Enterprises (NUS) Price Target Increased by 70.27% to 13.03
SeekingAlpha · Aug 11, 2026
Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call August 10, 2026 5:00 PM EDTCompany ParticipantsB.G.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
